Immunology and Microbiology
Human
97%
Monospecific Antibody
81%
Immunoglobulin G1
70%
Autoantibodies
64%
Isotype
64%
Molecular Mimicry
64%
Thymus
64%
Arbovirus
64%
Titer
64%
Intravenous Immunoglobulin
64%
Pharmacokinetics
64%
Antibody Response
60%
Antibody Titer
55%
Immunoglobulin M
50%
Peripheral Nerve
41%
Cross Reacting Antibody
41%
Viral Disease
36%
Cytomegalovirus
36%
Immunoglobulin G Antibody
36%
Ganglioside GM1 Antibody
36%
Cell Level
32%
B Cell
32%
Immunotherapy
32%
Infectious Agent
32%
Immunoglobulin A
32%
Epstein Barr Virus
27%
Dengue Virus
27%
Immunoglobulin M Antibody
27%
Hepatitis E Virus
18%
Virus Transmission
18%
Association
18%
ELISA
14%
Mycoplasma pneumoniae
13%
Campylobacter Jejuni
13%
Autoimmune Disease
11%
Serology
9%
Zika Virus
9%
Sample
9%
Time
9%
Virus
9%
Immune Response
9%
Antibody Blood Level
9%
Nerve Regeneration
9%
Immunity
9%
Antibody Production
9%
Immunoglobulin G4
5%
Immunoglobulin E
5%
Introspection
5%
Comprehension
5%
Evolution
5%
Neuroscience
Intravenous Immunoglobulin
100%
Thymus
64%
Coronavirus
64%
Epitope
32%
Immunoglobulin A
32%
B Cell
32%
Immunotherapy
32%
Ganglioside
32%
Immune-Mediated Neuropathy
32%
Cross Reacting Antibody
32%
Carbohydrates
32%
Antibodies
32%
Immunoglobulin M
32%
Speaking
32%
Cytomegalovirus
18%
Placebo
14%
Promoter Region
12%
Gene
12%
Phenotype
10%
Epstein-Barr Virus
9%
Hepatitis E Virus
9%
Genetic Variation
6%
Polyneuropathy
6%
Nervous System Disorder
5%
Intention
5%
Medicine and Dentistry
Infection
64%
Immunoglobulin
35%
Patient
32%
Cytomegalovirus
18%
Guillain-Barré Syndrome
16%
Therapeutic Procedure
14%
Epstein Barr Virus
9%
Hepatitis E Virus
9%
Association
9%
Symptom
9%
Adverse Event
5%
Amaurosis
5%
Intention-to-Treat Analysis
5%
Disability
5%